Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Bladder Cancer

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 43 articles: HTML format

Single Articles

June 2008
1. WANG M , Zhang Z, Zhu H, Fu G, et al
   A Novel Functional Polymorphism C1797G in the MDM2 Promoter Is Associated with Risk of Bladder Cancer in a Chinese Population.
   Clin Cancer Res. 2008;14:3633-40.
   PubMed     Related articles    Abstract available
   
   
   May 2008
2. KAWANISHI H , Matsui Y, Ito M, Watanabe J, et al
   Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer.
   Clin Cancer Res. 2008;14:2579-87.
   PubMed     Related articles    Abstract available
   
   
   
3. VEERAKUMARASIVAM A , Scott HE, Chin SF, Warren A, et al
   High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53.
   Clin Cancer Res. 2008;14:2527-34.
   PubMed     Related articles    Abstract available
   
   
   April 2008
4. YANG H , Gu J, Lin X, Grossman HB, et al
   Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
   Clin Cancer Res. 2008;14:2236-44.
   PubMed     Related articles    Abstract available
   
   
   
5. PIROLLO KF , Rait A, Zhou Q, Zhang XQ, et al
   Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo.
   Clin Cancer Res. 2008;14:2190-8.
   PubMed     Related articles    Abstract available
   
   
   March 2008
6. SITNIKOVA L , Mendese G, Liu Q, Woda BA, et al
   IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.
   Clin Cancer Res. 2008;14:1701-6.
   PubMed     Related articles    Abstract available
   
   
   
7. HADASCHIK BA , Adomat H, Fazli L, Fradet Y, et al
   Intravesical Chemotherapy of High-Grade Bladder Cancer with HTI-286, A Synthetic Analogue of the Marine Sponge Product Hemiasterlin.
   Clin Cancer Res. 2008;14:1510-1518.
   PubMed     Related articles    Abstract available
   
   
   
8. BLACK PC , Brown GA, Inamoto T, Shrader M, et al
   Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.
   Clin Cancer Res. 2008;14:1478-86.
   PubMed     Related articles    Abstract available
   
   
   February 2008
9. WU CL , Shieh GS, Chang CC, Yo YT, et al
   Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
   Clin Cancer Res. 2008;14:1228-38.
   PubMed     Related articles    Abstract available
   
   
   
10. FAN J , Stanfield J, Guo Y, Karam JA, et al
    Effect of trans-2,3-dimethoxycinnamoyl azide on enhancing antitumor activity of romidepsin on human bladder cancer.
    Clin Cancer Res. 2008;14:1200-7.
    PubMed     Related articles    Abstract available
    
    
    
11. HOLYOAKE A , O'Sullivan P, Pollock R, Best T, et al
    Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
    Clin Cancer Res. 2008;14:742-9.
    PubMed     Related articles    Abstract available
    
    
    January 2008
12. SABICHI AL , Lerner SP, Atkinson EN, Grossman HB, et al
    Phase III Prevention Trial of Fenretinide in Patients with Resected Non Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2008;14:224-229.
    PubMed     Related articles    Abstract available
    
    
    
13. SINGH RP , Tyagi A, Sharma G, Mohan S, et al
    Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
    Clin Cancer Res. 2008;14:300-8.
    PubMed     Related articles    Abstract available
    
    
    December 2007
14. YU J , Zhu T, Wang Z, Zhang H, et al
    A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Clin Cancer Res. 2007;13:7296-304.
    PubMed     Related articles    Abstract available
    
    
    October 2007
15. MORTON MJ , Zhang S, Lopez-Beltran A, MacLennan GT, et al
    Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder.
    Clin Cancer Res. 2007;13:6232-6.
    PubMed     Related articles    Abstract available
    
    
    August 2007
16. KIKUCHI E , Menendez S, Ozu C, Ohori M, et al
    Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Clin Cancer Res. 2007;13:4511-8.
    PubMed     Related articles    Abstract available
    
    
    
17. ALS AB , Dyrskjot L, von der Maase H, Koed K, et al
    Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer.
    Clin Cancer Res. 2007;13:4407-14.
    PubMed     Related articles    Abstract available
    
    
    
18. KARAM JA , Shariat SF, Huang HY, Pong RC, et al
    Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Clin Cancer Res. 2007;13.
    PubMed     Related articles    Abstract available
    
    
    July 2007
19. SMITH SC , Oxford G, Baras AS, Owens C, et al
    Expression of ral GTPases, their effectors, and activators in human bladder cancer.
    Clin Cancer Res. 2007;13:3803-13.
    PubMed     Related articles    Abstract available
    
    
    June 2007
20. DYRSKJOT L , Zieger K, Real FX, Malats N, et al
    Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.
    Clin Cancer Res. 2007;13:3545-51.
    PubMed     Related articles    Abstract available
    
    
    
21. SANCHEZ-CARBAYO M , Socci ND, Kirchoff T, Erill N, et al
    A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer.
    Clin Cancer Res. 2007;13:3215-20.
    PubMed     Related articles    Abstract available
    
    
    May 2007
22. KADER AK , Liu J, Shao L, Dinney CP, et al
    Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness.
    Clin Cancer Res. 2007;13:2614-20.
    PubMed     Related articles    Abstract available
    
    
    April 2007
23. YATES DR , Rehman I, Abbod MF, Meuth M, et al
    Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer.
    Clin Cancer Res. 2007;13:2046-2053.
    PubMed     Related articles    Abstract available
    
    
    March 2007
24. BAUMGART E , Cohen MS, Neto BS, Jacobs MA, et al
    Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Clin Cancer Res. 2007;13:1685-94.
    PubMed     Related articles    Abstract available
    
    
    
25. JAMIESON D , Wilson K, Pridgeon S, Margetts JP, et al
    NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Activity and Expression in Bladder and Ovarian Cancer and Lower NRH:Quinone Oxidoreductase 2 Activity Associated with an NQO2 Exon 3 Single-Nucleotide Polymorphism.
    Clin Cancer Res. 2007;13:1584-90.
    PubMed     Related articles    Abstract available
    
    
    February 2007
26. WANG X , Zhang S, MacLennan GT, Eble JN, et al
    Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
    Clin Cancer Res. 2007;13:953-7.
    PubMed     Related articles    Abstract available
    
    
    December 2006
27. MARGULIS V , Shariat SF, Ashfaq R, Sagalowsky AI, et al
    Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.
    Clin Cancer Res. 2006;12:7369-73.
    PubMed     Related articles    Abstract available
    
    
    
28. FROHLICH C , Albrechtsen R, Dyrskjot L, Rudkjaer L, et al
    Molecular Profiling of ADAM12 in Human Bladder Cancer.
    Clin Cancer Res. 2006;12:7359-7368.
    PubMed     Related articles    Abstract available
    
    
    November 2006
29. SHARIAT SF , Karakiewicz PI, Palapattu GS, Amiel GE, et al
    Nomograms provide improved accuracy for predicting survival after radical cystectomy.
    Clin Cancer Res. 2006;12:6663-76.
    PubMed     Related articles    Abstract available
    
    
    October 2006
30. LOPEZ-KNOWLES E , Hernandez S, Kogevinas M, Lloreta J, et al
    The p53 pathway and outcome among patients with T1G3 bladder tumors.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles    Abstract available
    
    
    August 2006
31. PATEL NS , Dobbie MS, Rochester M, Steers G, et al
    Up-Regulation of Endothelial Delta-like 4 Expression Correlates with Vessel Maturation in Bladder Cancer.
    Clin Cancer Res. 2006;12:4836-44.
    PubMed     Related articles    Abstract available
    
    
    
32. WANG XS , Zhang Z, Wang HC, Cai JL, et al
    Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.
    Clin Cancer Res. 2006;12:4851-8.
    PubMed     Related articles    Abstract available
    
    
    
33. BLEHM KN , Spiess PE, Bondaruk JE, Dujka ME, et al
    Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
    Clin Cancer Res. 2006;12:4671-7.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
34. KITAMURA H , Torigoe T, Honma I, Sato E, et al
    Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancer.
    Clin Cancer Res. 2006;12:4641-4.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    June 2006
35. OSMAN I , Bajorin DF, Sun TT, Zhong H, et al
    Novel blood biomarkers of human urinary bladder cancer.
    Clin Cancer Res. 2006;12:3374-80.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
36. SMALL EJ , Halabi S, Kantoff P, D'Amico A, et al
    Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles    Abstract available
    
    
    May 2006
37. KOSUGI M , Miyajima A, Kikuchi E, Horiguchi Y, et al
    Angiotensin II Type 1 Receptor Antagonist Candesartan as an Angiogenic Inhibitor in a Xenograft Model of Bladder Cancer.
    Clin Cancer Res. 2006;12:2888-93.
    PubMed     Related articles    Abstract available
    
    
    
38. YAMAMOTO Y , Matsuyama H, Kawauchi S, Furuya T, et al
    Biological characteristics in bladder cancer depend on the type of genetic instability.
    Clin Cancer Res. 2006;12:2752-8.
    PubMed     Related articles    Abstract available
    
    
    
39. LASCOMBE I , Clairotte A, Fauconnet S, Bernardini S, et al
    N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.
    Clin Cancer Res. 2006;12:2780-7.
    PubMed     Related articles    Abstract available
    
    
    April 2006
40. ISHIMURA H , Takahashi T, Nakagawa H, Nishimura S, et al
    N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer.
    Clin Cancer Res. 2006;12:2506-11.
    PubMed     Related articles    Abstract available
    
    
    
41. HENDRICKSEN K , Moonen PM, van der Heijden AG, Molkenboer-Kuenen J, et al
    Potential and toxicity of intravesical pemetrexed: a preclinical study in pigs.
    Clin Cancer Res. 2006;12:2597-601.
    PubMed     Related articles    Abstract available
    
    
    
42. URAKAMI S , Shiina H, Enokida H, Kawakami T, et al
    Combination Analysis of Hypermethylated Wnt-Antagonist Family Genes as a Novel Epigenetic Biomarker Panel for Bladder Cancer Detection.
    Clin Cancer Res. 2006;12:2109-2116.
    PubMed     Related articles    Abstract available
    
    
    November 2005
43. ZIEGER K , Dyrskjot L, Wiuf C, Jensen JL, et al
    Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
    Clin Cancer Res. 2005;11:7709-19.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: